GALT - GALECTIN THERAPEUTICS INC

QQQ $ 452.83 $ 3.91 (0.87 %)

DIA $ 399.31 $ 3.73 (0.94 %)

SPY $ 529.09 $ 3.17 (0.6 %)

TLT $ 92.14 $ 1.28 (1.41 %)

GLD $ 220.89 $ 2.79 (1.28 %)

Previous Close

$ 3.06

Open

$ 2.87

Bid

$ 3.04 x 200

Ask

$ 3.06 x 200

Day's Range

$ 2.84 - $ 3.12

52 Week Range

$ 1.28 - $ 4.27

Volume

171,102

Average Volume

Market Cap

176.01M

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-29-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-16-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	03-06-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-14-2018	06-30-2018	10-Q
25	05-11-2018	03-31-2018	10-Q
26	03-29-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-14-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-28-2017	12-31-2016	10-K
31	11-08-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-18-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

As Of March 31, 2024, Galectin Therapeutic...
05/15/2024 12:02:19

Galectin Therapeutics Q1 2024 GAAP EPS $(0...
05/15/2024 11:58:58

galectin-therapeutics-and-2-other-penny-stocks-insiders-are-buying

Galectin Therapeutics And 2 Other Penny St...
04/23/2024 10:53:53

HC Wainwright & Co. Reiterates Buy on Gale...
04/09/2024 15:57:49

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price ta...

Galectin Therapeutics Highlights Outcome O...
04/09/2024 13:26:30

Data and Safety Monitoring Board (DSMB) recommends the continuation, without modifications, of the adaptive Phase 2b/3 NAVIGATE...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
04/05/2024 16:31:08

HC Wainwright & Co. Reiterates Buy on Gale...
04/01/2024 16:21:47

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price ta...

Galectin Therapeutics: Q3 Earnings Insights
11/13/2023 13:50:06

Galectin Therapeutics' $20.4M Of Cash And ...
11/13/2023 13:23:55

Galectin Therapeutics Q3 EPS $(0.24) Misse...
11/13/2023 13:23:17

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate ...

Galectin Therapeutics Reports The Outcome ...
10/03/2023 12:02:57

Galectin Therapeutics, Inc.

Galectin Therapeutics To Present Update On...
09/26/2023 12:07:59

Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today announced it wil...

HC Wainwright & Co. Reiterates Buy on Gale...
08/15/2023 11:17:24

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price ta...

Galectin Therapeutics Q2 EPS $(0.15) Beats...
08/14/2023 12:21:00

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of...

Galectin Therapeutics And 3 Other Stocks U...
07/21/2023 11:24:34

The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their conf...

HC Wainwright & Co. Reiterates Buy on Gale...
05/17/2023 10:25:10

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price ta...

Galectin Therapeutics Q1 EPS $(0.19) Beats...
05/15/2023 12:18:41

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of...

Galectin Therapeutics Reports FY22 EPS Los...
03/30/2023 11:59:26

Galectin Therapeutics Reported The Outcome...
03/16/2023 12:08:29

The objective of this third independent DSMB was to further review the emerging tolerance and safety profiles of belapectin. Ba...

HC Wainwright & Co. Reiterates Buy on Gale...
03/03/2023 16:50:13

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price ta...